Sokoliuk Victoria, DiNardo James A, Brown Morgan L
From the Department of Cardiac Anesthesia, Boston Children's Hospital, Boston, Massachusetts.
A A Pract. 2019 Mar 15;12(6):205-207. doi: 10.1213/XAA.0000000000000885.
Pulmonary vein stenosis (PVS) is a progressive disease with pulmonary hypertension (PH) as a major cause of morbidity and mortality. Traditional management of PH with inhaled nitric oxide (iNO) is typically avoided in PVS patients because, while iNO may reduce pulmonary vascular resistance, PH persists as pulmonary blood flow increases in the presence of a downstream resistive lesion. We report 3 cases with primary PVS and PH in which iNO was used to successfully decrease mean pulmonary artery pressures with clinical improvement. Based on this experience, we suggest that iNO can be used to treat PH in select patients with PVS.
肺静脉狭窄(PVS)是一种进行性疾病,肺动脉高压(PH)是其发病和死亡的主要原因。PVS患者通常避免采用吸入一氧化氮(iNO)的传统方法治疗PH,因为尽管iNO可能降低肺血管阻力,但在存在下游阻力性病变的情况下,随着肺血流量增加,PH仍会持续存在。我们报告了3例原发性PVS和PH患者,其中使用iNO成功降低了平均肺动脉压并改善了临床症状。基于这一经验,我们建议iNO可用于治疗部分PVS患者的PH。